2016 annual financial data
BioMarin Pharmaceutical 2016 Operating margin
Direct answer
Operating margin was -71.94%.
Operating income was -803,429,000 USD and net income was -630,210,000 USD.
Operating cash flow was -227,837,000 USD.
Get free BioMarin Pharmaceutical email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,116,854,000 USD
- Operating income
- -803,429,000 USD
- Net income
- -630,210,000 USD
- Operating cash flow
- -227,837,000 USD